Sarah Cannon, the Cancer Institute of HCA Healthcare — Nashville, Tennessee

Sarah Cannon, the Cancer Institute of HCA Healthcare is a clinical research site located in Nashville, Tennessee, United States 37203.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

Sarah Cannon, the Cancer Institute of HCA Healthcare has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: Acute Myeloid Leukemia.

Sponsors: Stemline Therapeutics, Inc..

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Sarah Cannon, the Cancer Institute of HCA Healthcare?

Sarah Cannon, the Cancer Institute of HCA Healthcare has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Sarah Cannon, the Cancer Institute of HCA Healthcare conducted?

Sarah Cannon, the Cancer Institute of HCA Healthcare has 1 clinical trials on record, with 1 currently active. Their work covers Acute Myeloid Leukemia.

Is Sarah Cannon, the Cancer Institute of HCA Healthcare accredited by Crixeo Health?

Sarah Cannon, the Cancer Institute of HCA Healthcare has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Sarah Cannon, the Cancer Institute of HCA Healthcare?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.